Disclosure of Invention
The invention aims to provide N, N-disubstituted-4- (5- (trifluoromethyl) -1,2, 4-oxadiazole-3-yl) benzamide compounds, and a preparation method and application thereof.
In order to achieve the above purpose, the present invention adopts the following technical scheme:
N, N-disubstituted-4- (5- (trifluoromethyl) -1,2, 4-oxadiazol-3-yl) benzamide compounds have the structural formula shown in formula I:
Wherein R 1 is selected from methoxy or phenyl, R 2 is selected from 4-methylphenyl, 4-methylbenzyl, 4-methoxyphenyl, 4-methoxybenzyl, 4-chlorobenzyl, 4-bromobenzyl, 3-trifluoromethylphenyl or 4-trifluoromethylbenzyl.
Further, the N, N-disubstituted-4- (5- (trifluoromethyl) -1,2, 4-oxadiazol-3-yl) benzamide compound is selected from the group consisting of compounds I-1, I-2, I-3, I-4, I-5 and I-6, and the structural formulas of the I-1, I-2, I-3, I-4, I-5 and I-6 are as follows:
the preparation method of the N, N-disubstituted-4- (5- (trifluoromethyl) -1,2, 4-oxadiazole-3-yl) benzamide compound has the following reaction formula:
Wherein R 1 is selected from methoxy or phenyl, R 2 is selected from 4-methylphenyl, 4-methylbenzyl, 4-methoxyphenyl, 4-methoxybenzyl, 4-chlorobenzyl, 4-bromobenzyl, 3-trifluoromethylphenyl or 4-trifluoromethylbenzyl. The amounts of the respective reaction raw materials may be referred to those known to those skilled in the art.
The invention also provides application of the N, N-disubstituted-4- (5- (trifluoromethyl) -1,2, 4-oxadiazole-3-yl) benzamide compound in preventing and controlling plant pathogenic fungi.
Preferably, the plant pathogenic fungus is Phytospora viticola (Botryosphaeria dothidea) or Pythium aphanidermatum (Pythium aphanidermatum).
The invention also provides a bactericide which contains at least one of the N, N-disubstituted-4- (5- (trifluoromethyl) -1,2, 4-oxadiazol-3-yl) benzamide compounds with a bactericidal effective dose and optionally contains auxiliary materials.
Preferably, the bactericide is at least one of emulsifiable concentrate, suspending agent, wettable powder, granule, water aqua, mother solution or mother powder.
The invention has the beneficial effects that:
(1) The N, N-disubstituted-4- (5- (trifluoromethyl) -1,2, 4-oxadiazole-3-yl) benzamide compound is designed and synthesized by taking amide as a framework, taking 4- (5- (trifluoromethyl) -1,2, 4-oxadiazole as an acid part of the amide and taking a hydrophobic benzene ring as an amine part, has novel molecular structure and clear chemical structural characteristics, and has a good effect on preventing and treating Botrytis cinerea (Botryosphaeria dothidea) and melon and fruit mould (Pythium aphanidermatum) because the N, N-disubstituted-4- (5- (trifluoromethyl) -1,2, 4-oxadiazole-3-yl) benzamide compound is connected with the N, N-disubstituted amine group and the 5-trifluoromethyl oxadiazole benzoic acid through amide bonds.
(2) The preparation method of the compound is simple and convenient, the raw materials are easy to obtain, and the reaction conditions are easy to control. For example, in the step of synthesizing N, N-disubstituted-4- (5- (trifluoromethyl) -1,2, 4-oxadiazole-3-yl) benzamide compounds, the product is obtained through column chromatography.
(3) The compound provided by the invention has good crop safety, can be developed into a novel plant bactericide, and is used for preventing and controlling plant pathogenic fungi in the agricultural or forestry field.
Detailed Description
In order that the above-recited objects, features and advantages of the present invention will become more apparent, a more particular description of the invention will be rendered by reference to specific embodiments thereof which are illustrated in the appended drawings.
In the following description, numerous specific details are set forth in order to provide a thorough understanding of the present invention, but the present invention may be practiced in other ways other than those described herein, and persons skilled in the art will readily appreciate that the present invention is not limited to the specific embodiments disclosed below.
The procedures and methods not described in detail in the examples below are conventional methods well known in the art, and the reagents used in the examples are all analytically or chemically pure and are either commercially available or prepared by methods well known to those of ordinary skill in the art. The following examples all achieve the object of the invention.
The preparation method of the N, N-disubstituted-4- (5- (trifluoromethyl) -1,2, 4-oxadiazole-3-yl) benzamide compound in the embodiment of the invention has the following reaction formula:
Example 1
Preparation of N-phenyl-N- (4-methoxybenzyl) -4- (5- (trifluoromethyl) -1,2, 4-oxadiazol-3-yl) benzamide compound:
(1) Dissolving 4-cyanobenzoic acid (0.034 mol) in 50mL of absolute ethyl alcohol and 20mL of water, stirring uniformly, adding absolute sodium carbonate (0.0506 mol), hydroxylamine hydrochloride (0.0626 mol) and 8-hydroxyquinoline (0.0017 mol) under stirring, heating the reaction solution to reflux temperature for reacting for 5 hours, monitoring the raw materials by TLC to react completely, cooling to room temperature, decompressing to remove ethanol, filtering out precipitated solid, adjusting pH to 5-6, stirring for 0.5h, filtering the solid again, washing with distilled water, and drying in vacuum at 60 ℃ to obtain a white solid intermediate 1;
(2) Placing the intermediate 1 into a 250mL single-port bottle, adding 60mL of dry tetrahydrofuran, cooling to 0-5 ℃ in an ice bath, dissolving trifluoroacetic anhydride (0.0408 mol) in 60mL of tetrahydrofuran, diluting and slowly dripping to a reaction liquid, removing the ice bath, stirring for 5h, monitoring the raw materials by TLC to react completely, concentrating under reduced pressure to obtain a solid, adding distilled water, stirring for 2h, filtering out the solid, and drying at 60 ℃ in vacuum to obtain an off-white solid intermediate 2, namely 4- (5- (trifluoromethyl) -1,2, 4-oxadiazol-3-yl) benzoic acid;
(3) Placing the intermediate 2 into a dry reaction bottle, adding thionyl chloride, heating to reflux temperature, stirring for 3h, cooling to room temperature, and concentrating under reduced pressure to obtain a crude product of the intermediate 3, namely 4- (5- (trifluoromethyl) -1,2, 4-oxadiazol-3-yl) benzoyl chloride. Wherein, the intermediate 3 should be used at present;
(4) In a dry reaction bottle, adding N-phenyl-1- (4-methoxyphenyl) ethylamine equivalent to the intermediate 3 and triethylamine equivalent to 1.5 times, dissolving the intermediate 3 in dichloromethane uniformly, stirring and dripping the mixture into a reaction liquid under ice bath, and reacting for 3-8 hours. TLC monitoring the reaction completion of the starting material, washing the organic layer with water (10 mL. Times.3), washing with saturated brine (10 mL. Times.3), drying, suction-filtering, concentrating under reduced pressure to remove dichloromethane to obtain crude product, and purifying with chromatography column (eluent petroleum ether: ethyl acetate=20:1) to obtain the target compound I-1. The yield thereof was found to be 67.5%.
I-1 pale yellow oily matter .1H NMR(600MHz,CDCl3)δ1.52(d,J=7.2Hz,3H,CH3),3.82(s,3H,OCH3),6.39(s,1H,CH),6.63(s,2H,C6H4OMe 3,5-H),6.85(d,J=8.6Hz,2H,C6H4OMe 2,6-H),7.11–7.04(m,3H,C6H5 3,4,5-H),7.23(d,J=8.2Hz,2H,C6H52,6-H),7.37(d,J=7.8Hz,2H,C6H4-oxadiazole 3,5-H),7.86(d,J=7.9Hz,2H,C6H4-oxadiazole 2,6-H).HRMS:HR-MS(ESI):m/z calcd for C25H20F3N3O3[M+H]+468.1530,found 468.1512.
Example 2
Steps (1) - (4) are the same as in example 1, wherein in step (4), N-phenyl-1- (4-methoxybenzyl) ethylamine is used to replace N-phenyl-1- (4-methoxyphenyl) ethylamine in example 1, and the target compound I-2 is obtained. The yield thereof was found to be 72.1%.
I-2 pale yellow oily matter .1H NMR(600MHz,CDCl3)δ1.30(d,J=6.7Hz,3H,CH3),2.72(dd,J=13.5,7.6Hz,1H,CH2),3.24(dd,J=12.9,7.6Hz,1H,CH),3.81(s,3H,OCH3),4.93(d,J=4.8Hz,1H,CH),6.82(s,2H,C6H4OMe 3,5-H),6.87(d,J=8.4Hz,2H,C6H4OMe 2,6-H),7.14(d,J=6.7Hz,3H,C6H5 3,4,5-H),7.21(d,J=7.2Hz,2H,C6H5 2,6-H),7.29(d,J=7.8Hz,2H,C6H4-oxadiazole 3,5-H),7.85(d,J=7.5Hz,2H,C6H4-oxadiazole 2,6-H).HRMS:HR-MS(ESI):m/z calcd for C26H22F3N3O3[M+H]+482.1686,found 482.1696.
Example 3
Steps (1) - (4) are the same as in example 1, wherein in step (4), N-phenyl-1- (4-methoxyphenyl) ethylamine in example 1 is replaced with N-phenyl-1- (4-bromobenzyl) ethylamine to obtain the target compound I-3. The yield thereof was found to be 73.2%.
I-3 pale yellow oily matter ,1H NMR(600MHz,CDCl3)δ1.30(d,J=6.8Hz,3H,CH3),2.72(dd,J=13.7,7.8Hz,1H,CH2),3.26(dd,J=13.3,7.6Hz,1H,CH2),4.95(d,J=5.8Hz,1H,CH),6.82(d,J=5.6Hz,2H,C6H4Br 2,6-H),7.21–7.12(m,5H,C6H5),7.28(d,J=7.9Hz,2H,C6H4Br 3,5-H),7.45(d,J=8.1Hz,2H,C6H4-oxadiazole 3,5-H),7.86(d,J=7.8Hz,2H,C6H4oxadiazole 2,6-H).HRMS:HR-MS(ESI):m/z calcd for C25H19BrF3N3O2[M+H]+530.0686,found 530.0692.
Example 4
Steps (1) - (4) are the same as in example 1, wherein in step (4), N-methoxy-1- (4-nitrobenzyl) ethylamine is used to replace N-phenyl-1- (4-methoxyphenyl) ethylamine in example 1, and the target compound I-4 is obtained. The yield thereof was found to be 65.0%.
I-4 pale yellow oily matter ,1H NMR(600MHz,CDCl3)δ1.48(d,J=6.7Hz,3H,CH3),2.98–2.82(m,1H,CH2),3.27(dd,J=13.5,9.4Hz,1H,CH2),3.63(s,3H,OCH3),4.66(s,1H,CH),7.38(m,4H,C6H4NO2 2,6-H,C6H4-oxadiazole 3,5-H),8.10–8.05(m,2H,C6H4-oxadiazole 2,6-H,),8.14(dd,J=8.4,3.3Hz,2H,C6H4NO2 3,5-H).HRMS:HR-MS(ESI):m/z calcd for C20H17F3N4O5[M+H]+451.1224,found 451.1234.
Example 5
Steps (1) - (4) are the same as in example 1, wherein in step (4), N-phenyl-1- (4-methoxyphenyl) ethylamine in example 1 is replaced with N-phenyl-1- (4-trifluoromethylphenyl) ethylamine to obtain the target compound I-5. The yield thereof was found to be 66.7%.
I-5 pale yellow oily matter ,1H NMR(600MHz,CDCl3)δ1.58(d,J=7.2Hz,3H,CH3),6.41(d,J=6.6Hz,1H,CH),6.67(s,2H,C6H4CF3 2,6-H),7.12(dt,J=19.7,6.9Hz,3H,C6H53,4,5-H),7.38(d,J=8.3Hz,2H,C6H4CF3 3,5-H),7.48(d,J=8.0Hz,2H,C6H5 2,6-H),7.60(d,J=8.2Hz,2H,C6H4-oxadiazole 3,5-H),7.88(d,J=8.3Hz,2H,C6H4-oxadiazole2,6-H).HRMS:HR-MS(ESI):m/z calcd for C25H17F6N3O2[M+H]+506.1298,found506.1308.
Example 6
Steps (1) - (4) are the same as in example 1, wherein in step (4), N-phenyl-1- (4-methoxyphenyl) ethylamine in example 1 is replaced with N-phenyl-1- (4-chlorobenzyl) ethylamine to obtain a target compound I-6. Yield 73.1%
I-6 pale yellow oily matter .1H NMR(600MHz,CDCl3)δ1.31(d,J=6.8Hz,3H,CH3),2.74(dd,J=13.7,7.7Hz,1H,CH2),3.28(dd,J=13.3,7.6Hz,1H,CH2),4.95(d,J=5.8Hz,1H,CH),6.82(d,J=5.5Hz,2H,C6H4Cl 2,6-H),7.16(d,J=7.0Hz,3H,C6H53,4,5-H),7.23(d,J=7.6Hz,2H,C6H4Cl 3,5-H),7.29(t,J=9.0Hz,4H,C6H5 2,6-H,C6H4-oxadiazole 3,5-H),7.86(d,J=7.8Hz,2H,C6H4-oxadiazole 2,6-H).HRMS:HR-MS(ESI):m/z calcd for C25H19ClF3N3O2[M+H]+486.1191,found 486.1201.
Example 7
Sterilization Activity (ex vivo) experiment
The plant fungi used in this example were Portugal fungus (Botryosphaeria dothidea) and Pythium aphanidermatum (Pythium aphanidermatum) stored at 4℃in the laboratory.
The culture medium is potato agarose culture medium (PDA for short). The PDA culture medium formula comprises 200g of potato (peeled), 20g of glucose, 15g of agar and 1000mL of distilled water, wherein the PDA culture medium is prepared by cleaning and peeling the potato, weighing 200g of potato, cutting into small pieces, adding water, boiling for 20-30min, puncturing by a glass rod, filtering by eight layers of gauze, adding 20g of agar and 20g of glucose in sequence according to experimental requirements, stirring uniformly, fully dissolving, slightly cooling, supplementing water to 1000mL, sub-packaging, sterilizing at 121 ℃ for 30min, and cooling for later use.
The experimental method adopts a hypha growth rate method and comprises the following steps:
(1) Firstly, culturing the plant fungi on a PDA plate at 25 ℃ for about 3-6 days for standby;
(2) Heating PDA culture medium to dissolve, cooling to 45-50deg.C, proportionally adding 10 μl of 20mg/mL compound to be tested to obtain culture medium containing 100 μg/mL liquid medicine, and respectively pouring into culture dish for cooling;
(3) Taking circular fungus cakes (with the diameter of 0.5 cm) from the edge of hypha of each strain cultivated for 6d (the growing condition is as consistent as possible) by using a puncher through aseptic operation procedures, picking the circular fungus cakes to the center of a medicine-containing flat plate by using an inoculating needle, and then inverting a culture dish into an incubator for cultivation;
(4) Observing and measuring the growth condition of hyphae at different times after treatment, measuring the diameter by adopting a crisscross method, processing data, and calculating the inhibition rate;
Each treatment was repeated 3 times.
The test results are shown in Table 1.
TABLE 1 inhibition of Compound I-1~I-6 at a concentration of 100mg/mL for different fungi (%)
Given the general inhibitory activity of some of the target compounds against Puccinia (Botryosphaeria dothidea) and Pythium aphanidermatum (Pythium aphanidermatum), it can be seen from Table 1 that compound I-3 has optimal inhibitory activity against Puccinia (Botryosphaeria dothidea) and Pythium aphanidermatum (Pythium aphanidermatum).
The N, N-disubstituted-4- (5- (trifluoromethyl) -1,2, 4-oxadiazole-3-yl) benzamide compound has obvious structural difference and clear chemical structural characteristics, and has good effects on preventing and treating the Botrytis cinerea (Botryosphaeria dothidea) and the aphanidermatum (Pythium aphanidermatum). The compound can be used for preventing and controlling plant fungal diseases in agriculture or forestry, and has the advantages of simple preparation method, high yield and stable product property. Has potential application value for drug development of plant pathogen resistance.